12.56 USD
▲+0.08+0.64%
盘后 13.70 0.00%
2026-11-13
市值
$775.87M
市盈率
—
EPS
-31.84
股息率
—
52 周区间
5.70 – 49.97
成交量
314.04K
Beta
3.06
目标价
39.00
52W 低 5.7052W 高 49.97
价格走势
公司简介
Obsidian Therapeutics, Inc. operates as a clinical-stage biotechnology company developing engineered cell and gene therapies. The company is developing investigational therapies, including OBX-115, which is being evaluated in clinical trials for advanced solid tumors, advanced melanoma, and relapsed refractory non-small cell lung cancer. It utilizes a proprietary Cytodriver technology platform designed to regulate protein function using FDA-approved small-molecule drugs and is advancing tumor-infiltrating lymphocyte (TIL) cell therapies that le...